Method for alleviating psoriasis

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 70, 424168, 424238, 424284, 424305, 424310, 424315, 424317, A61K 3147, A61K 31355, A61K 31215, A61K 31195

Patent

active

041817257

ABSTRACT:
Pharmaceutical compositions administered to humans and animals topically for treatment of proliferative skin diseases, primarily psoriasis. The composition comprises a pharmaceutical carrier with at least one active ingredient selected from the group consisting of para bromophenacyl bromide, alpha tocopherol, mepacrine, chloroquine, hydroxychloroquine, dibucaine, tetracaine, lidocaine, butacaine, procaine, ethylene diamine tetra acetic acid and ethylene glycol bis(.beta.-amino ethyl ether)-N-N' tetra acetic acid; the compositions may also include one or more unsaturated aliphatic compounds, a glucocorticoid and a prostaglandin.

REFERENCES:
patent: 3033884 (1962-05-01), Osbond et al.
patent: 3450821 (1969-06-01), Cartesen et al.
patent: 3903297 (1975-09-01), Robert
The Merck Index, 9th Edition, 1976, pp. 183, 191, 276, 399, 463, 637, 717, 1005, 1044, 1183, 1184, 1290.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for alleviating psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for alleviating psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for alleviating psoriasis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2120323

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.